Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators

Heart Rhythm

Volumn 9, Issue 1, 2012, Pages 42-46

  Kramer, Daniel B ^a   Friedman, Paul A ^b   Kallinen, Linda M ^c   Morrison, Thomas Ben ^b   Crusan, Daniel J ^b   Hodge, David O ^b   Reynolds, Matthew R ^a   Hauser, Robert G ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

Implantable cardioverter defibrillators; Outcomes research

Indexed keywords

CREATININE;

ACCURACY; ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEFIBRILLATOR; FATALITY; FEMALE; GRAFT RECIPIENT; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFORMATION PROCESSING; INSTRUMENT VALIDATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RISK REDUCTION; TERTIARY HEALTH CARE;

AGED; ARRHYTHMIAS, CARDIAC; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84655169973     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.08.031     Document Type: Article

References (33)

1. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
2. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
3. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, G. Hafley Multicenter Unsustained Tachycardia Trial Investigators A randomized study of the prevention of sudden death in patients with coronary artery disease N Engl J Med 341 1999 1882 1890
4. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
5. A.S. Desai, J.C. Fang, W.H. Maisel, K.L. Baughman Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2004 2874 2879 (Pubitemid 39628235)
6. R. Tung, P. Zimetbaum, M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
7. L.W. Stevenson, A.S. Desai Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure J Card Fail 12 2006 407 412 (Pubitemid 46110776)
8. L.W. Stevenson Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: are there enough bangs for the bucks? Circulation 114 2006 101 103 (Pubitemid 44420740)
9. M.J. Eisenberg Risk stratification for arrhythmic events: are the bangs worth the bucks? J Am Coll Cardiol 38 2001 1912 1915 (Pubitemid 33116563)
10. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
11. P.S. Cuculich, J.M. Sanchez, R. Kerzner Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death Pacing Clin Electrophysiol 30 2007 207 213 (Pubitemid 46333676)
12. I. Goldenberg, A.J. Moss Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality J Cardiovasc Electrophysiol 19 2008 1281 1283
13. C.S. Hager, S. Jain, J. Blackwell, B. Culp, J. Song, C.D. Chiles Effect of renal function on survival after implantable cardioverter defibrillator placement Am J Cardiol 106 2010 1297 1300
14. R. Parkash, W.G. Stevenson, L.M. Epstein, W.H. Maisel Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection Am Heart J 151 2006 397 403 (Pubitemid 43144742)
15. D.B. Kramer, M.E. Josephson Three questions for evidence-based cardiac electrophysiology Circ Cardiovasc Qual Outcomes 3 2010 704 709
16. D.K. Owens, G.D. Sanders, P.A. Heidenreich, K.M. McDonald, M.A. Hlatky Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator Am Heart J 144 2002 440 448
17. M.A. Hlatky, D.B. Mark The high cost of implantable defibrillators Eur Heart J 28 2007 388 391 (Pubitemid 47343553)
18. M.A. Hlatky, G.D. Sanders, D.K. Owens Cost-effectiveness of the implantable cardioverter defibrillator Card Electrophysiol Rev 7 2003 479 482
19. I. Goldenberg, A.K. Vyas, W.J. Hall Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
20. A.E. Buxton, K.L. Lee, G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157 (Pubitemid 47375017)
21. W.C. Levy, K.L. Lee, A.S. Hellkamp Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842
22. R.J. Myerburg, V. Reddy, A. Castellanos Indications for implantable cardioverter-defibrillators based on evidence and judgment J Am Coll Cardiol 54 2009 747 763
23. S.M. Al-Khatib, A. Hellkamp, J. Curtis Non-evidence-based ICD implantations in the United States JAMA 305 2011 43 49
24. S. Ziesche, T.S. Rector, J.N. Cohn Interobserver discordance in the classification of mechanisms of death in studies of heart failure J Card Fail 1 1995 127 132
25. G.A. Upadhyay, N.K. Choudhry, A. Auricchio, J. Ruskin, J.P. Singh Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies J Am Coll Cardiol 52 2008 1239 1246
26. M.O. Sweeney Wood shop, Sun Tzu, and patient selection for cardiac resynchronization therapy Heart Rhythm 8 2011 1095 1098
27. D.E. Haines, Y. Wang, J. Curtis Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation Circulation 123 2011 2069 2076
28. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
29. M.H. Criqui, R.D. Langer, A. Fronek Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
30. D.B. Kramer, A.L. Ottenberg, S. Gerhardson "Just because we can doesn't mean we should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators J Interv Card Electrophysiol 2011 Jul 30 [Epub ahead of print]
31. D.B. Kramer, D.W. Brock, U.B. Tedrow Informed consent in cardiac resynchronization therapy: what should be said? Circ Cardiovasc Qual Outcomes 4 5 2011 Sep 1 573 577
32. A.E. Buxton Sudden cardiac death won't go away: What are we to do? Heart Rhythm 8 2011 1183 1184
33. J.J. Goldberger, A.E. Buxton, M. Cain Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks Circulation 123 2011 2423 2430